Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Montanova Capital, LLC's stake in Monte Rosa Therapeutics, Inc. fell to 4.20% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Montanova Capital, LLC's stake in Monte Rosa Therapeutics, Inc. fell to 4.20%, 3,549,539 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
4.20%
Shares
3,549,539
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Montanova Capital, LLC4.20%3,549,539
Averill Master Fund, Ltd.3.80%3,215,486
Aaron Cowen4.20%3,549,539

Source

View original at SEC

Related